Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells

Molecular Biology Reports

Volumn 38, Issue 6, 2011, Pages 4159-4170

  Da Silva, Glenda N ^a   Evangelista, Adriane F ^b   Magalhaẽs, Danielle A ^b   Macedo, Cláudia ^b   Búfalo, Michelle C ^a   Sakamoto Hojo, Elza T ^b   Passos, Geraldo A S ^b   Salvadori, Daisy M F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gene expression; Gene network; TP53; Urinary bladder transitional cell carcinoma

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN P53; TYROSINE;

ANLN GENE; APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; CODON; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE CLUSTER; GENE DELETION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE REGULATORY NETWORK; GENETIC ANALYSIS; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; S100P GENE; SIGNAL TRANSDUCTION; TRANSITIONAL CELL CARCINOMA; WILD TYPE;

APOPTOSIS; BAYES THEOREM; CELL CYCLE; CELL LINE, TUMOR; CLUSTER ANALYSIS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, NEOPLASM; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 80052476245     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0536-x     Document Type: Article

References (51)

1. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M, Weider J (2005) Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66:4-34. (Pubitemid 43049607)
2. Cookson MS, Herr W, Zhang ZF, Soloway S, Sogani PC, Fair WR (1997) The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158:62-67. (Pubitemid 27251595)
3. Nishiyama H, Habuchi T, Watanabe J, Teramukai S, Tada H, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O (2004) Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. Eur Urol 45:176-181. (Pubitemid 38147824)
4. Cordon-Cardo C (2008) Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol Suppl 218:154-165.
5. Wolff EM, Liang G, Jones PA (2005) Mechanisms of disease: genetic and epigenetic alterations that drive bladder cancer. Nat Clin Pract Urol 2:502-510. (Pubitemid 41594404)
6. Levine A (2005) The p53 tumor-suppressor gene. N Engl J Med 1992(326):1350-1352.
7. Sengupta S, Harris CC (2005) p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6:44-55. (Pubitemid 40064898)
8. Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, Cordon-Cardo C (2002) Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 62:6973-6980. (Pubitemid 35424089)
9. Sanchez-Carbayo M, Socci ND, Richstone L, Corton M, Behrendt N, Wulkfuhle J, Bochner B, Petricoin E, Cordon-Cardo C (2007) Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression. Am J Pathol 171:1650-1658. (Pubitemid 350158325)
10. Coppée J-Y (2008) Do DNA microarrays have their future behind them? Microbes Infect 10:1067-1071.
11. Grant GR, Manduchi E, Stoeckert Jr CJ (2007) Analysis and management of microarray gene expression data. Curr Protoc Mol Biol, Chapter 19: Unit 19.6.
12. Kraemer K, Schmidt U, Fuessel S, Herr A, Wirth MP, Meye A (2006) Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR. Int J Cancer 119: 1276-1284. (Pubitemid 44258800)
13. Kikuchi T, Daigo Y, Katagiri T, Tsunoda T, Okada K, Kakiuchi S, Zembutsu H, Furukawa Y, Kawamura M, Kobayashi K, Imai K, Nakamura Y (2003) Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22:2192-2205. (Pubitemid 36539569)
14. Staege M, Banning-Eichenseer U, Weibflog G, Volkmer I, Burdach S, Richter G, Mauz-Korholz C, Foll J, Korholz D (2008) Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs. Exp Hematol 36:886-896.
15. Cooper MJ, Haluschak JJ, Johsond D, Schwartz S, Morrison LJ, Lippa M, Hatzivassiliou G, Tan J (1994) p53 mutations in bladder carcinoma cell lines. Oncol Res 6:569-579.
16. Rieger KM, Little AF, Swart JM, Kastrinakis WV, Fitzgerald JM, Hess DT, Libertino JA, Summerhayes IC (1995) Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer 72:683-690.
17. da Silva GN, Marcondes JPC, Camargo EA, Passos GAS, Sakamoto- Hojo ET, Salvadori DMF (2010) Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine. Exp Biol Med 235:814-824.
18. Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, Hughes JE, Snesrud E, Lee N, Quackenbush J (2000) A concise guide to cDNA microarray analysis. Biotechniques 29: 548-550, 552-544, 556 passim.
19. Spot software [http://www.tm4.org/spotfinder.html].
20. Ihaka R, Gentleman R (1996) A language for data analysis and graphics. J Comput Graph Stat 5:299-314.
21. KTH package [http://www.biotech.kth.se/molbio/microarray/].
22. Yang YH, Speed T (2002) Design issues for cDNA microarray experiments. Nat Rev Genet 3:579-588. (Pubitemid 34827132)
23. MEV software [http://www.tm4.org/mev.html].
24. S.O.U.R.C.E. [http://smd-www.stanford.edu/cgi-bin/source/sourceSearch].
25. NCBI [http://www.ncbi.nlm.nih.gov/].
26. FATIGO [http://babelomics.bioinfo.cipf.es/].
27. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. PNAS 98:5116-5121. (Pubitemid 32397092)
28. Gene Network [http://idv.sinica.edu.tw/hchuang/GeneNetwork1.2Setup.exe].
29. Blaveri E, Simko JP, James JE, Brewer JL, Baehner F, DeVries KS, Koppie T, Pejavar S, Carroll P, Waldman F (2005) Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Research 11:4044-4055. (Pubitemid 40791568)
30. Kato S (2003) Understanding the function structure and function mutation relationships of p53 tumor suppressor protein by high resolution missense mutation analysis. Proc Natl Acad Sci USA 100:8424-8429. (Pubitemid 36842561)
31. Brosh R, Rotter V (2009) When mutations gain new powers: news from the mutant p53 field. Nat Rev Cancer 10:701-713.
32. Prives C, Manfredi JJ (2005) The continuing saga of p53-More sleepless nighs ahead. Mol Cell 19:719-721. (Pubitemid 41316665)
33. Zhao S, Zhang J, Zhang X, Dong X, Sun X (2008) Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep 35:421-429.
34. Savopoulos JW, Carter PS, Turconi S, Pettman GR, Karran EH, Gray CW, Ward RV, Jenkins O, Creasy CL (2000) Expression, purification, and functional analysis of the human serine protease HtrA2. Protein Expr Purif 19:227-234. (Pubitemid 30446301)
35. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM (1998) An induced proximity model for caspase-8 activation. J Biol Chem 273:2926-2930. (Pubitemid 28133943)
36. Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY, Xiav QC (2004) Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 4:982-994. (Pubitemid 38445958)
37. Hinata N, Shirakawa T, Zhang Z, Matsumoto A, Fujisawa M, Okada H, Kamidono S, Gotoh A (2003) Radiation induces p53- dependent cell apoptosis in bladder câncer cells with wild-typep53 but not in p53-mutated bladder cancer cells. Urol Res 31:387-396. (Pubitemid 38004924)
38. Esrig D, Spruck CH 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ (1993) p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143:1389-1397. (Pubitemid 24057109)
39. Fujita T, Kobayashi Y, Wada O, Tateishi Y, Kitada L, Yamamoto Y, Takashima H, Murayama A, Yano T, Baba T, Kato S, Kawabe Y-I, Yanagisawa J (2003) Full activation of estrogen receptor- activation function-1 induces proliferation of breast cancer cells. J Biol Chemistry 29:26704-26714. (Pubitemid 36876816)
40. Hecker C-M, Rabiller M, Haglund K, Bayer P, Dikic I (2006) Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chemistry 281:16117-16127. (Pubitemid 43848507)
41. Niki T, Galli I, Ariga H, Iguchi-Ariga SMM (2000) MSSP, a protein binding to an origin of replication in the c-myc gene, interacts with a catalytic subunit of DNA polymerase a and stimulates its polymerase activity. FEBS Letters 475:209-212. (Pubitemid 30408455)
42. Kortmansky J, Shah MA, Kaubisch A (2005) Phase I trial of thecyclin- dependent kinase inhibitor and protein kinase C inhibitor 7- hydroxystaurosporine in combination with fluorouracil in patients with advanced solid tumors. J Clin Oncol 23:1875-1884. (Pubitemid 46211365)
43. Hart FU (1996) Molecular chaperones in cellular protein folding. Nature 381:571-579.
44. Moussa O, Yordy JS, Abol-Enein H, Sinha D, Bissada NK, Haluska PV, Ghoneim MA, Watson DK (2005) Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res 65:11581-11587. (Pubitemid 41821717)
45. Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2202:654-662. (Pubitemid 40175840)
46. Yang Q, Liu S, Tian Y, Hasan C, Kersey D, Salwen HR, Chlenski A, Perlman EJ, Cohn SL (2004) Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Res 64:4531-4538. (Pubitemid 38856925)
47. Wang L, He G, Zhang P, Wang X, Jiang M, Yu L (2010) Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. Mol Biol Rep [Epub ahead of print].
48. Yuan J, Tang W, Luo K, Chen X, Gu X, Wan B, Yu L (2006) Cloning and characterization of the human gene DERP6, which activates transcriptional activities of p53. Mol Biol Rep 33:151-158. (Pubitemid 44087086)
49. Soussi T, Wiman KG (2007) Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 12:303-312. (Pubitemid 47539312)
50. Guerreiro Da Silva IS, Hu YF, Russo IH, Ao X, Salicioni AM, Yang X, Russo J (2000) S100P calciumbinding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int J Oncol 16:231-240.
51. Oegema K, Savoian MS, Matchinson TJ, Field CM (2000) Functional analysis of a human homologue of the Drosophila actin binding protein anillin suggests a role in cytokinesis. J Cell Biol 150:539-551. (Pubitemid 30641399)